ABVC vs GILD: Which Stock is Better?

Side-by-side comparison of Abvc Biopharma Inc and Gilead Sciences Inc in 2026

Comparison Updated:

ABVC

Abvc Biopharma Inc

$2.15

GILD

Gilead Sciences Inc

$124.14

Key Metrics Comparison

MetricABVCGILDWinner
Market Cap$49.09M$154.99BGILD
P/E RatioN/A19.34GILD
EPS (TTM)$N/A$6.46GILD
Revenue Growth1.0%0.0%ABVC
Gross Margin100.0%78.7%ABVC

Analyze ABVC

Full quant analysis

Analyze GILD

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is ABVC or GILD a better investment?

Comparing ABVC and GILD: Abvc Biopharma Inc has a market cap of $49.09M while Gilead Sciences Inc has $154.99B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between ABVC and GILD?

ABVC (Abvc Biopharma Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: ABVC or GILD?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: ABVC or GILD?

ABVC has higher revenue growth at 1.0% vs 0.0% for GILD.

Which company is more profitable: ABVC or GILD?

Abvc Biopharma Inc (ABVC) has higher gross margins at 100.0% compared to 78.7% for GILD.

Which is the larger company: ABVC or GILD?

Gilead Sciences Inc (GILD) is larger with a market cap of $154.99B compared to $49.09M for ABVC.

Should I buy ABVC or GILD in 2026?

Both ABVC and GILD have investment merit. ABVC trades at $2.15 while GILD trades at $124.14. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between ABVC and GILD stock?

Key differences: Market Cap ($49.09M vs $154.99B), P/E Ratio (N/A vs 19.3x), Revenue Growth (1.0% vs 0.0%), Gross Margin (100.0% vs 78.7%).

Popular Stock Comparisons